Bray, F., Laversanne, M., Sung, H., et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Ca-Cancer J. Clin., 2024, vol. 74, no. 3, pp. 229—263. https://doi.org/10.3322/caac.21834
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al., Cancer statistics, 2022, Ca-Cancer J. Clin., 2022, vol. 72, no. 1, pp. 7—33. https://doi.org/10.3322/caac.21708
To, B., Isaac, D., and Andrechek, E.R., Studying lymphatic metastasis in breast cancer: current models, strategies, and clinical perspectives, J. Mammary Gland Biol. Neoplasia, 2020, vol. 25, no. 3, pp. 191—203. https://doi.org/10.1007/s10911-020-09460-5
Kim, M.Y., Breast cancer metastasis, Adv. Exp. Med. Biol., 2021, vol. 1187, pp. 183—204. https://doi.org/10.1007/978-981-32-9620-6_9
Article CAS PubMed Google Scholar
Shukla, S., Penta, D., Mondal, P., et al., Epigenetics of breast cancer: clinical status of epi-drugs and phytochemicals, Adv. Exp. Med. Biol., 2019, vol. 1152, pp. 293—310. https://doi.org/10.1007/978-3-030-20301-6_16
Article CAS PubMed Google Scholar
Rahman, M.M., Brane, A.C., and Tollefsbol, T.O., MicroRNAs and epigenetics strategies to reverse breast cancer, Cells, 2019, vol. 8, no. 10. https://doi.org/10.3390/cells8101214
Cervena, K., Siskova, A., Buchler, T., et al., Methylation-based therapies for colorectal cancer, Cells, 2020, vol. 9, no. 6. https://doi.org/10.3390/cells9061540
Yan, H. and Bu, P., Non-coding RNA in cancer, Essays Biochem., 2021, vol. 65, no. 4, pp. 625—639. https://doi.org/10.1042/EBC20200032
Article CAS PubMed PubMed Central Google Scholar
Ahmadpour, S.T., Orre, C., Bertevello, P.S., et al., Breast cancer chemoresistance: insights into the regulatory role of lncRNA, Int. J. Mol. Sci., 2023, vol. 24, no. 21, p. 15897. https://doi.org/10.3390/ijms242115897
Article CAS PubMed PubMed Central Google Scholar
Yang, F. and Lv, S., LncRNA EPB41L4A-AS1 regulates cell proliferation, apoptosis and metastasis in breast cancer, Ann. Clin. Lab. Sci., 2022, vol. 52, no. 1, pp. 3—11. Erratum in: Ann. Clin. Lab. Sci., 2022, vol. 52, no. 3, p. 510.
Hashemi, M., Moosavi, M.S., Abed, H.M., et al., Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy, Pharmacol. Res., 2022, vol. 184. https://doi.org/10.1016/j.phrs.2022.106418
Kim, J., Piao, H.L., Kim, B.J., et al., Long noncoding RNA MALAT1 suppresses breast cancer metastasis, Nat. Genet., 2018, vol. 50, no. 12, pp. 1705—1715. https://doi.org/10.1038/s41588-018-0252-3
Article CAS PubMed PubMed Central Google Scholar
TNM Classification of Malignant Tumours, Brierley, J.D., Gospodarowicz, M.K., and Chichester, C.W., Eds., Chichester: Wiley, 2017, 8th ed.
World Medical Association, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, JAMA, 2013, vol. 310, no. 20, pp. 2191—2194. https://doi.org/10.1001/jama.2013.281053
Loginov, V.I., Pronina, I.V., Filippova, E.A., et al., Aberrant methylation of 20 miRNA genes specifically involved in various steps of ovarian carcinoma spread: from primary tumors to peritoneal macroscopic metastases, Int. J. Mol. Sci., 2022, vol. 23, no. 3. https://doi.org/10.3390/ijms23031300
Wu, J., Xiao, Y., Xia, C., et al., Identification of biomarkers for predicting lymph node metastasis of stomach cancer using clinical DNA methylation data, Dis. Markers, 2017, vol. 2017. https://doi.org/10.1155/2017/5745724
Teschendorff, A.E., Gao, Y., Jones, A., et al., DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer, Nat. Commun., 2016, vol. 29, no. 7. https://doi.org/10.1038/ncomms10478
Lu, L., Zhu, G., Zhang, C., et al., Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer, Breast Cancer Res. Treat., 2012, vol. 136, no. 3, pp. 875—883. https://doi.org/10.1007/s10549-012-2314-z
Article CAS PubMed Google Scholar
Selezneva, A.D., Filippova, E.A., Selezneva, A.D., et al., Hypermethylation of long non-coding RNA genes group in the breast cancer development and progression, Bull. Exp. Biol. Med., 2022, vol. 173, no. 6, pp. 765—769. https://doi.org/10.1007/s10517-022-05627-8
Article CAS PubMed Google Scholar
Liu, W., Zhan, J., Zhong, R., et al., Upregulation of long noncoding RNA_GAS5 suppresses cell proliferation and metastasis in laryngeal cancer via regulating PI3K/AKT/mTOR signaling pathway, Technol. Cancer Res. Treat., 2021, vol. 20. https://doi.org/10.1177/1533033821990074
Sadeghalvad, M., Mansouri, K., Mohammadi-Motlagh, H.R., et al., Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells, Rev. Assoc. Med. Bras., 2022, vol. 68, no. 4, pp. 456—462. https://doi.org/10.1590/1806-9282.20210966
Yu, X., Duan, W., Wu, F., et al., LncRNA-HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR-664b-3p/Rheb/mTOR pathway, Cancer Sci., 2023, vol. 114, no. 9, pp. 3537—3552. https://doi.org/10.1111/cas.15881
留言 (0)